The January DCI Seminar Series, to be held on Wednesday, January 20, will feature Yossi Shiloh, PhD,director of The David and Inez Myers Laboratory for Cancer Genetics, Department of Human Molecular Genetics and Biochemistry, at Tel Aviv University School of Medicine.
The title of his talk is “Ataxia-telangiectasia: presenting the genome (in) stability-cellular homeostasis link.”
Shiloh has dedicated most of his scientific career to understanding a rare, devastating genetic disorder called ataxia-telangiectasia (A-T). He began his work on A-T while working on his PhD thesis and this quest culminated in 1995 in the identification of the responsible gene, ATM, in his lab.
The lab has since been studying the function and mode of action of the ATM gene product – the ATM protein, while continuing its quest to understand A-T. In addition to his research, he gives popular scientific lectures to the general public on the medical, social and ethical implications of the genome revolution.
Shiloh obtained his PhD in Human Genetics at The Hebrew University of Jerusalem and trained further at Harvard Medical School, the University of Michigan, New York University Cancer Center, Memorial Sloan Kettering Cancer Center, Rockefeller University and the National Institutes of Health (at NIH as a Fogarty Fellow).
He is a member of The Israel National Academy of Sciences and Humanities. Awards include the 2005 EMET Prize in Life Sciences, the 2011 American Association of Cancer Research G.H.A. Clowes Memorial Award for Outstanding Accomplishments in Cancer Research, the 2011 Israel Prize in Life Sciences, and the 2015 Olav Thon Prize in Natural Sciences and Medicine (Oslo, Norway).
Shiloh's lecture begins at 8 a.m. and ends at 9 a.m. The January DCI Seminar Series is presented by Duke Cancer Institute's Radiation Oncology & Imaging Program and held in conjunction with Hematology Oncology Grand Rounds.
For more information and to access the Webex link, email Joan Lofton, MBA, AGM.